FARN — Faron Pharmaceuticals Oy Cashflow Statement
0.000.00%
Last trade - 00:00- £216.42m
- £224.19m
Annual cashflow statement for Faron Pharmaceuticals Oy, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.9 | -21.2 | -28.7 | -30.9 | -25.9 |
| Depreciation | |||||
| Non-Cash Items | 0.075 | 0.485 | 1.65 | 4.88 | 8.3 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.901 | -1.82 | 3.79 | 1.91 | -5.67 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -17.5 | -22.2 | -23 | -23.8 | -23 |
| Capital Expenditures | -0.142 | -0.474 | -0.385 | -0.123 | -0.226 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0.001 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.142 | -0.473 | -0.385 | -0.123 | -0.226 |
| Financing Cash Flow Items | 0.371 | -0.318 | -0.135 | -1.11 | -5.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.8 | 25.6 | 23.5 | 24 | 25.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.95 | 2.75 | 0.137 | -0.114 | 2.63 |